Logo image of CRWV

COREWEAVE INC-CL A (CRWV) Stock Fundamental Analysis

NASDAQ:CRWV - Nasdaq - US21873S1087 - Common Stock - Currency: USD

41.54  -0.23 (-0.55%)

After market: 41.65 +0.11 (+0.26%)

Fundamental Rating

0

Taking everything into account, CRWV scores 0 out of 10 in our fundamental rating. CRWV was compared to 0 industry peers in the Unkown industry. CRWV has a bad profitability rating. Also its financial health evaluation is rather negative. CRWV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CRWV has reported negative net income.
CRWV Yearly Net Income VS EBIT VS OCF VS FCFCRWV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 2B -2B -4B

1.2 Ratios

Industry RankSector Rank
ROA -6.63%
ROE -68.03%
ROIC 2.52%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CRWV Yearly ROA, ROE, ROICCRWV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 100 200 300 400

1.3 Margins

Industry RankSector Rank
OM 16.93%
PM (TTM) N/A
GM 74.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CRWV Yearly Profit, Operating, Gross MarginsCRWV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 -100 -200

More info and screens

0

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CRWV is destroying value.
CRWV has about the same amout of shares outstanding than it did 1 year ago.
CRWV has a worse debt/assets ratio than last year.
CRWV Yearly Shares OutstandingCRWV Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 100M 200M 300M 400M
CRWV Yearly Total Debt VS Total AssetsCRWV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 5B 10B 15B

2.2 Solvency

CRWV has an Altman-Z score of 0.82. This is a bad value and indicates that CRWV is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 2.51 is on the high side and indicates that CRWV has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 2.51
Debt/FCF N/A
Altman-Z 0.82
ROIC/WACC0.29
WACC8.79%
CRWV Yearly LT Debt VS Equity VS FCFCRWV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 2B -2B 4B -4B

2.3 Liquidity

CRWV has a Current Ratio of 0.52. This is a bad value and indicates that CRWV is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.52 indicates that CRWV may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.52
CRWV Yearly Current Assets VS Current LiabilitesCRWV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 1B 2B 3B 4B

More info and screens

1

3. Growth

3.1 Past

CRWV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -57.81%.
CRWV shows a strong growth in Revenue. In the last year, the Revenue has grown by 736.64%.
EPS 1Y (TTM)-57.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.05%
Revenue 1Y (TTM)736.64%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%544.35%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CRWV Yearly Revenue VS EstimatesCRWV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 500M 1B 1.5B

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CRWV. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CRWV Price Earnings VS Forward Price EarningsCRWV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 18.95
CRWV Per share dataCRWV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CRWV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COREWEAVE INC-CL A

NASDAQ:CRWV (4/25/2025, 4:30:00 PM)

After market: 41.65 +0.11 (+0.26%)

41.54

-0.23 (-0.55%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner Change75.51%
Market Cap19.28B
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 10.06
P/FCF N/A
P/OCF N/A
P/B 13.99
P/tB 14.24
EV/EBITDA 18.95
EPS(TTM)-2.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.13
BVpS2.97
TBVpS2.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.63%
ROE -68.03%
ROCE 3.19%
ROIC 2.52%
ROICexc 2.91%
ROICexgc 2.92%
OM 16.93%
PM (TTM) N/A
GM 74.24%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 2.51
Debt/FCF N/A
Debt/EBITDA 2.91
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.52
Altman-Z 0.82
F-ScoreN/A
WACC8.79%
ROIC/WACC0.29
Cap/Depr(3y)1492.86%
Cap/Depr(5y)N/A
Cap/Sales(3y)732.41%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.05%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)736.64%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%544.35%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2344.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-436.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.01%
OCF growth 3YN/A
OCF growth 5YN/A